These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 28794253
21. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. Singer W, Opfer-Gehrking TL, McPhee BR, Hilz MJ, Bharucha AE, Low PA. J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1294-8. PubMed ID: 12933939 [Abstract] [Full Text] [Related]
22. Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Jankovic J, Gilden JL, Hiner BC, Kaufmann H, Brown DC, Coghlan CH, Rubin M, Fouad-Tarazi FM. Am J Med; 1993 Jul; 95(1):38-48. PubMed ID: 7687093 [Abstract] [Full Text] [Related]
23. Treatment of orthostatic hypotension with midodrine and octreotide. Hoeldtke RD, Horvath GG, Bryner KD, Hobbs GR. J Clin Endocrinol Metab; 1998 Feb; 83(2):339-43. PubMed ID: 9467537 [Abstract] [Full Text] [Related]
24. Midodrine in neurogenic orthostatic hypotension. A new treatment. Gilden JL. Int Angiol; 1993 Jun; 12(2):125-31. PubMed ID: 7690383 [Abstract] [Full Text] [Related]
25. Intradialytic hypotension: is midodrine beneficial in symptomatic hemodialysis patients? Cruz DN, Mahnensmith RL, Perazella MA. Am J Kidney Dis; 1997 Dec; 30(6):772-9. PubMed ID: 9398120 [Abstract] [Full Text] [Related]
26. A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Wright RA, Kaufmann HC, Perera R, Opfer-Gehrking TL, McElligott MA, Sheng KN, Low PA. Neurology; 1998 Jul; 51(1):120-4. PubMed ID: 9674789 [Abstract] [Full Text] [Related]
27. Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials. Chen JJ, Han Y, Tang J, Portillo I, Hauser RA, Dashtipour K. Ann Pharmacother; 2018 Dec; 52(12):1182-1194. PubMed ID: 29972032 [Abstract] [Full Text] [Related]
28. Management of coexistent neurogenic orthostatic hypotension and supine hypertension. Cannom DS. J Clin Hypertens (Greenwich); 2019 Nov; 21(11):1732-1734. PubMed ID: 31599484 [No Abstract] [Full Text] [Related]
29. Midodrine. A review of its therapeutic use in the management of orthostatic hypotension. McClellan KJ, Wiseman LR, Wilde MI. Drugs Aging; 1998 Jan; 12(1):76-86. PubMed ID: 9467688 [Abstract] [Full Text] [Related]
35. [Pyridostigmine in the treatment of primary orthostatic hypotension]. Monge Argiles JA, Leiva Santana C. Neurologia; 2007 May; 22(4):260-2. PubMed ID: 17492522 [Abstract] [Full Text] [Related]
36. Effectiveness of droxidopa compared to midodrine in standing blood pressure and orthostatic tolerance in adults with neurogenic orthostatic hypotension: a systematic review protocol. Patrick K, Martin T. JBI Database System Rev Implement Rep; 2017 Sep; 15(9):2287-2294. PubMed ID: 28902695 [Abstract] [Full Text] [Related]
37. Case report: severe myoclonus associated with oral midodrine treatment for hypotension. Ye X, Ling B, Wu J, Wu S, Ren Y, Zhang H, Song F, Xuan Z, Chen M. Medicine (Baltimore); 2020 Oct 02; 99(40):e21533. PubMed ID: 33019383 [Abstract] [Full Text] [Related]
38. The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale. Kaufmann H, Malamut R, Norcliffe-Kaufmann L, Rosa K, Freeman R. Clin Auton Res; 2012 Apr 02; 22(2):79-90. PubMed ID: 22045363 [Abstract] [Full Text] [Related]